Home > Benztropine mesylate > White blood cell count increased > Benztropine mesylate and White blood cell count increased
Review: could Benztropine mesylate cause White blood cell count increased?
We study 2,522 people who have side effects while taking Benztropine mesylate from FDA and social media. Among them, 43 have White blood cell count increased. Find out below who they are, when they have White blood cell count increased and more.
Get connected: join a mobile support group for people who take Benztropine mesylate and have White blood cell count increased >>>
Benztropine mesylate (latest outcomes from 2,575 users) has active ingredients of benztropine mesylate. It is often used in na.
White blood cell count increased
White blood cell count increased (latest reports from 131,861 patients) has been reported by people with schizophrenia, high blood pressure, multiple sclerosis, depression, rheumatoid arthritis.
On Oct, 13, 2014: 2,522 people reported to have side effects when taking Benztropine mesylate. Among them, 43 people (1.70%) have White Blood Cell Count Increased.
Time on Benztropine mesylate when people have White blood cell count increased * :
Gender of people who have White blood cell count increased when taking Benztropine mesylate * :
|White blood cell count increased||26.09%||73.91% |
Age of people who have White blood cell count increased when taking Benztropine mesylate * :
|White blood cell count increased||0.00%||0.00%||2.27%||4.55%||15.91%||29.55%||29.55%||18.18% |
Top conditions involved for these people * :
- Schizophrenia (21 people, 48.84%)
- Metastases to bone (2 people, 4.65%)
- Agitation (2 people, 4.65%)
- Insomnia (2 people, 4.65%)
- Schizophrenia, undifferentiated type (2 people, 4.65%)
Top co-used drugs for these people * :
- Clozapine (21 people, 48.84%)
- Clonazepam (10 people, 23.26%)
- Lorazepam (8 people, 18.60%)
- Clozaril (7 people, 16.28%)
- Ambien (7 people, 16.28%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have White Blood Cell Count Increased while taking Benztropine Mesylate?
Get connected! Join a mobile support group:
- support group for people who take Benztropine mesylate and have White Blood Cell Count Increased
- support group for people who take Benztropine mesylate
- support group for people who have White Blood Cell Count Increased
Comments from related studies:
From this study (2 months ago):
Patient was given medication for over two months; then passed away due to respiratory distress, renal failure, and other complications. Showed signs of allergic reaction but physicians did not stop treatment.
From this study (6 months ago):
My WBC count was 15.6 last week before taking Valtrex, now after finding many cherry angiomas since starting the Valtrex I was taken off the medicine and had more blood tests run. Now my WBC count is 16.1 after being on the medicine for almost a week.
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Benztropine mesylate, White blood cell count increased
More reviews for: Benztropine mesylate, White blood cell count increased
On eHealthMe, Benztropine Mesylate (benztropine mesylate) is often used for tardive dyskinesia. Find out below the conditions Benztropine Mesylate is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Benztropine Mesylate used for and how effective is it:
Other drugs that are used to treat the same conditions:
Drugs in real world that are associated with:
Could your condition cause it?
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.